Dianthus Therapeutics Inc (NAS:DNTH) Stock News, Headlines & Updates
Dianthus Therapeutics Inc Stock News from GuruFocus
- 1
Jun 28, 2024
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)
GlobeNewswire • 11:00am
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)
Marketwired • 11:00am
Jun 12, 2024
Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)
Marketwired • 6:00am
May 30, 2024
Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference
Marketwired • 4:00pm
May 08, 2024
Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference
Marketwired • 4:00pm
May 03, 2024
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Apr 11, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news